339 related articles for article (PubMed ID: 709782)
1. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens.
Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM
Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782
[TBL] [Abstract][Full Text] [Related]
2. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia.
Mason JW; Winkle RA
Circulation; 1978 Dec; 58(6):971-85. PubMed ID: 709781
[TBL] [Abstract][Full Text] [Related]
3. Availability of electrophysiological approach to the selection and assessment of antiarrhythmic drugs for recurrent ventricular tachycardia.
Kasanuki H; Ohnishi S; Hirosawa K
Jpn Circ J; 1983 Jan; 47(1):105-23. PubMed ID: 6827769
[TBL] [Abstract][Full Text] [Related]
4. The response to procainamide during electrophysiologic study for sustained ventricular tachyarrhythmias predicts the response to other medications.
Waxman HL; Buxton AE; Sadowski LM; Josephson ME
Circulation; 1983 Jan; 67(1):30-7. PubMed ID: 6847803
[TBL] [Abstract][Full Text] [Related]
5. [Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia].
Mendoza I; Moleiro F; Castellanos A; Casal H; Arends E; Medina V
Arch Inst Cardiol Mex; 1982; 52(4):301-11. PubMed ID: 7138133
[TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic drug combinations in the treatment of ventricular tachycardia.
Ross DL; Sze DY; Keefe DL; Swerdlow CD; Echt DS; Griffin JC; Winkle RA; Mason JW
Circulation; 1982 Dec; 66(6):1205-10. PubMed ID: 6814784
[TBL] [Abstract][Full Text] [Related]
7. Long-term lorcainide therapy in patients with ventricular tachycardia.
Somberg J; Butler B; Flowers D; Keefe D; Torres V; Miura D
Am Heart J; 1985 Jan; 109(1):33-40. PubMed ID: 3966330
[TBL] [Abstract][Full Text] [Related]
8. Long term lorcainide therapy guided by electrophysiology studies.
Somberg J; Butler B; Flowers D; Tepper D; Torres V
Acta Cardiol; 1985; 40(6):621-36. PubMed ID: 3879419
[TBL] [Abstract][Full Text] [Related]
9. Effects of intravenous disopyramide and quinidine on normal myocardium and on the characteristics of arrhythmias: intraindividual comparison in patients with sustained ventricular tachycardia.
Rizos I; Brachmann J; Lengfelder W; Schmitt C; von Olshausen K; Kübler W; Senges J
Eur Heart J; 1987 Feb; 8(2):154-63. PubMed ID: 3569310
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced narrowing of the width of the zone of entrainment as a predictor of the subsequent non-inducibility of reentrant ventricular tachycardia after an additional dose of an antiarrhythmic drug.
Aizawa Y; Chinushi M; Naitoh N; Shibata A
Heart; 1996 Feb; 75(2):165-70. PubMed ID: 8673755
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of isoproterenol on sustained ventricular tachycardia before and during procainamide and quinidine antiarrhythmic drug therapy.
Markel ML; Miles WM; Luck JC; Klein LS; Prystowsky EN
Circulation; 1993 Mar; 87(3):783-92. PubMed ID: 8443899
[TBL] [Abstract][Full Text] [Related]
13. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN
Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic drug therapy for sustained ventricular tachycardia.
Kienzle MG; Williams PD; Zygmont D; Doherty JU; Josephson ME
Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of lorcainide in patients with symptomatic ventricular tachycardia.
Somberg JC; Butler B; Flowers D; Keefe D; Torres V; Miura D
Am J Cardiol; 1984 Aug; 54(4):43B-48B. PubMed ID: 6465046
[TBL] [Abstract][Full Text] [Related]
17. Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia.
Griffith MJ; Linker NJ; Garratt CJ; Ward DE; Camm AJ
Lancet; 1990 Sep; 336(8716):670-3. PubMed ID: 1975861
[TBL] [Abstract][Full Text] [Related]
18. Electropharmacologic testing in sustained ventricular tachycardia associated with coronary heart disease: value of the response to intravenous procainamide in predicting the response to oral procainamide and oral quinidine treatment.
Oseran DS; Gang ES; Rosenthal ME; Mandel WJ; Peter T
Am J Cardiol; 1985 Nov; 56(13):883-6. PubMed ID: 3904387
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide.
Karagueuzian HS; Sugi K; Ohta M; Meesmann M; Ino T; Peter T; Mandel WJ
Am Heart J; 1986 Dec; 112(6):1173-83. PubMed ID: 3788764
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of propranolol added to a type I antiarrhythmic agent for sustained ventricular tachycardia secondary to coronary artery disease.
Friehling TD; Lipshutz H; Marinchak RA; Stohler JL; Kowey PR
Am J Cardiol; 1990 Jun; 65(20):1328-33. PubMed ID: 2343820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
